Aller au contenu principal

Belapectin


Belapectin


Belapectin (also known as GR-MD-02) is a galectin-3 inhibitor developed by Galectin Therapeutics that is in clinical trials for the treatment of non-alcoholic steatohepatitis.

References



Text submitted to CC-BY-SA license. Source: Belapectin by Wikipedia (Historical)


INVESTIGATION